Kink, John A.
Bellio, Michael A.
Forsberg, Matthew H.
Lobo, Alexandra
Thickens, Anna S.
Lewis, Bryson M.
Ong, Irene M.
Khan, Aisha
Capitini, Christian M. http://orcid.org/0000-0002-2276-6731
Hematti, Peiman
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HHSN268201600012I, R01 HL153721, HHSN268201600012I, R01 HL153721)
U.S. National Library of Medicine (5T15LM007359)
St. Baldrick's Foundation
Article History
Received: 10 July 2023
Accepted: 28 February 2024
First Online: 13 March 2024
Declarations
:
: All human studies were conducted using a University of Wisconsin-Madison IRB-approved protocol (2016–0298, entitled collection of discarded bone marrow and peripheral blood cell bag products, approved 3/28/16). All murine studies were conducted using a protocol approved by the Animal Care and Use Committee at the University of Wisconsin-Madison (M005915, entitled immunotherapy of cancer after bone marrow transplant and cellular therapy, approved 10/13/20).
: Not applicable.
: J.A.K., P.H. and C.M.C. are inventors on patents related to this publication (US Patents 10,166,254 and 11,499,730). C.M.C. reports honorarium from Bayer, Elephas, Nektar Therapeutics, Novartis and WiCell Research Institute, who had no input in the study design, analysis, manuscript preparation, or decision to submit for publication. No other relevant conflicts of interest are reported.